Author

T. Battelino

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Human genomics in Europe: from national and pan-European initiatives to genomic medicine

Advances in high-throughput sequencing technologies have transformed human genomics, enabling large-scale initiatives to characterise genome structure, function, and population diversity. Following foundational international projects such as the Human Genome Project, HapMap, and the 1000 Genomes Project, many countri...

Špela Gruden, Lucija Raspor dall'Olio, J. Hancock et al. · Human Genomics · 0 citations

Open access Sep 2026

Exploratory Analysis of Continuous Glucose Monitoring Patterns in First-Degree Relatives with Dysglycemia at Risk of Progression to Stage 3 Type 1 Diabetes.

INTRODUCTION Continuous glucose monitoring (CGM) can characterize subtle glucose changes in early-stage type 1 diabetes (T1D). We assessed whether CGM metrics predict Stage 3 T1D in first-degree relatives (FDRs) with positive islet autoantibodies (IAbs) and dysglycemia participating in INNODIA. METHODS We analyzed IA...

Olivier G. Pollé, T. Battelino, Pieter-Jan Martens et al. · Diabetes Technology & Therap... · 0 citations

Open access Sep 2026

Effect of rosuvastatin and ezetimibe therapy on LDL-cholesterol reduction and non-invasive arterial injury markers in children with heterozygous familial hypercholesterolemia: a prospective, open-label, randomized study

Individuals with familial hypercholesterolemia (FH) require early lipid-lowering therapy (LLT). We compared rosuvastatin versus ezetimibe treatment and the role of major non-invasive arterial injury markers in children with heterozygous FH. In this prospective, open-label, randomized study, 45 children with...

A. Skarlovnik, Tevž Gorjanc, J. Šikonja et al. · Frontiers in Cardiovascular... · 0 citations